Abstract
The effect of the antiepileptic medication sodium valproate (VPA) on the concentrations of cerebral metabolites was studied longitudinally in ten patients with epilepsy using proton magnetic resonance spectroscopy (MRS). Myo-inositol was found to be lower while taking VPA, although no relationship between the change in metabolite concentration, VPA dose or seizure control was observed. MRS findings should be interpreted in the light of administered medications.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Adolescent
-
Adult
-
Algorithms
-
Anticonvulsants / pharmacology*
-
Brain Chemistry / drug effects*
-
Dipeptides / metabolism
-
Epilepsy / drug therapy
-
Epilepsy / metabolism*
-
Female
-
Glutamic Acid / metabolism
-
Glutamine / metabolism
-
Humans
-
Inositol / metabolism
-
Longitudinal Studies
-
Magnetic Resonance Imaging
-
Magnetic Resonance Spectroscopy
-
Male
-
Middle Aged
-
Valproic Acid / pharmacology*
Substances
-
Anticonvulsants
-
Dipeptides
-
Glutamine
-
isospaglumic acid
-
Glutamic Acid
-
Inositol
-
Valproic Acid